Bibliography
- BROPHY JM: Celecoxib and cardiovascular risks. Expert Opin. Drug Saf. (2005) 4:1005-1015.
- BANNWARTH B: Do selective cyclo-oxygenase-2 inhibitors have a future? Drug Saf. (2005) 28:183-189.
- SOLOMON DH: Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum. (2005) 52:1968-1978.
- AW TJ, HAAS J, LIEW D, KRUM H: Meta-analysis of cyclo-oxygenase-2 inhibitors and their effects on blood pressure. Arch. Intern. Med. (2005) 165:490-496.
- STROM B: Pharmacoepidemiology (3rd Edn), John Wiley & Sons (2001).
Website
- http://www.fda.gov/cder/drug/infopage/cox2 Analysis and recommendations for Agency action regarding non-steroidal anti-inflammatory drugs and cardiovascular riks.